FDA approved Priovant's Lisraya (brepocitinib) as the first targeted therapy for dermatomyositis, Gilead's Bixlenvo as the ...
President Donald Trump’s administration is preparing to announce a new round of drug-pricing agreements with midsize biotech ...
Eli Lilly and Company announced results from a real-world study of adults over 55 with obesity or overweight showing that ...
With biopharma batch failures averaging every 40 weeks, predictive maintenance and connected monitoring are becoming critical ...
Osivax and GC Biopharma team up on a next-generation flu vaccine, K2 Therapeutics' Ying Huang talks through why so few drugs ...
ACTO CEO Parth Khanna on why sales reps still matter — and how human intelligence plus empathetic agents is the winning formula for field teams.
FDA approves Imaavy as the first treatment for warm autoimmune hemolytic anemia, McKesson agrees to acquire Precision ...
The FDA has approved daraxonrasib (brand name Rasonque) for adults with metastatic pancreatic adenocarcinoma who have ...
A new Eli Lilly study links Zepbound to lower healthcare costs in older adults with obesity, Biohaven and Haisco strike major ...
Evolving global expectations for CGT validation, comparability, and supply continuity elevate the need for operational and ...
K2 Therapeutics CEO Ying Huang on the drug development pipeline — and the compounding attrition rates that make FDA approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results